Paper Details 
Original Abstract of the Article :
Lactic acidosis is a rare but serious side effect in individuals receiving nucleoside reverse transcriptase inhibitors. An underweight woman with HIV was admitted to our hospital because of nausea and diffuse myalgia. Her antiretroviral regimen had been changed to tenofovir disoproxil fumarate (TDF)...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626898/

データ提供:米国国立医学図書館(NLM)

Tenofovir Disoproxil Fumarate and Lactic Acidosis: A Cautionary Tale

The world of HIV treatment is a complex desert, with a constant search for new oases of hope. This case report explores a rare but serious side effect of [tenofovir disoproxil fumarate (TDF)], a common antiretroviral medication. The researchers describe a case of [severe lactic acidosis] in an underweight woman with HIV who was receiving a combination of TDF, emtricitabine, darunavir, and cobicistat. They hypothesized that [the patient's low body weight, combined with cobicistat, led to elevated tenofovir levels], contributing to mitochondrial damage and lactic acidosis. This case report highlights the importance of careful monitoring and individualized treatment approaches in managing HIV patients.

Tenofovir and Lactic Acidosis: A Balancing Act in HIV Treatment

This case report serves as a cautionary tale, reminding us of the potential risks associated with TDF, particularly in underweight patients. The desert of HIV treatment is full of complex considerations, and this research underscores the importance of careful monitoring and individualized care for patients receiving TDF-containing regimens.

Navigating the Desert of HIV Treatment: Prioritizing Patient Safety

This case report highlights the need for vigilance in monitoring HIV patients receiving TDF-containing regimens, especially those with low body weight. The desert of HIV treatment is full of potential challenges, and we must prioritize patient safety to ensure a smooth and healthy journey through treatment.

Dr. Camel's Conclusion

This case report emphasizes the importance of careful monitoring and individualized treatment approaches in managing HIV patients, particularly when using TDF-containing regimens. The desert of HIV treatment is full of complexities, and this research reminds us to navigate this terrain with caution and prioritize patient safety to ensure a healthy and fulfilling journey for those affected by this formidable disease.

Date :
  1. Date Completed 2023-11-15
  2. Date Revised 2023-11-15
Further Info :

Pubmed ID

37923339

DOI: Digital Object Identifier

PMC10626898

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.